| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699268 | Clinical Oncology | 2011 | 6 Pages |
Abstract
Hypofractionated accelerated radiotherapy with concurrent carboplatin achieves a high local control. This regimen should be considered for a radiotherapy dose-escalation study using intensity-modulated radiotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.K. Chan, P. Sanghera, B.A. Choo, C. McConkey, H. Mehanna, S. Parmar, P. Pracy, J. Glaholm, A. Hartley,